These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 3486912)

  • 41. Lymphokines regulate immunoglobulin isotype expression in an antigen-specific immune response.
    Tesch H; Müller W; Rajewsky K
    J Immunol; 1986 Apr; 136(8):2892-5. PubMed ID: 2420875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Soluble factors involved in B cell differentiation: identification of two distinct T cell-replacing factors (TRF).
    Nakanishi K; Howard M; Muraguchi A; Farrar J; Takatsu K; Hamaoka T; Paul WE
    J Immunol; 1983 May; 130(5):2219-24. PubMed ID: 6601148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential expression of cell activation markers after stimulation of resting human B lymphocytes.
    Kehrl JH; Muraguchi A; Fauci AS
    J Immunol; 1984 Jun; 132(6):2857-61. PubMed ID: 6427329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and partial purification of a B cell growth-promoting material utilizing the BCL1 cell line.
    Thoman ML; Weigle WO
    J Immunol; 1983 Jan; 130(1):233-6. PubMed ID: 6600179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line.
    Yoshizaki K; Nakagawa T; Fukunaga K; Tseng LT; Yamamura Y; Kishimoto T
    J Immunol; 1984 Jun; 132(6):2948-54. PubMed ID: 6202767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of B cell growth factor (BCGF) by monoclonal antibodies directed against the C3d receptor (CR2).
    Perri RT; Wilson BS; Kay NE
    Eur J Immunol; 1986 Apr; 16(4):350-5. PubMed ID: 2938967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. G0 B cells activated by anti-mu acquire the ability to proliferate in response to B cell-activating factors independently from entry into G1 phase.
    Proust JJ; Chrest FJ; Buchholz MA; Nordin AA
    J Immunol; 1985 Nov; 135(5):3056-61. PubMed ID: 3900202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of IL-2-induced human B cell proliferation in the presence of human 50-kDa B cell growth factor and IL-4.
    Vazquez A; Mills S; Maizel A
    J Immunol; 1989 Jan; 142(1):94-9. PubMed ID: 2783328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Production of B cell growth factor by a Leu-7+, OKM1+ non-T cell with the features of large granular lymphocytes (LGL).
    Pistoia V; Cozzolino F; Torcia M; Castigli E; Ferrarini M
    J Immunol; 1985 May; 134(5):3179-84. PubMed ID: 3920315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human helper T cell factor(s). IV. Demonstration of a human late-acting B cell differentiation factor acting on Staphylococcus aureus Cowan I-stimulated B cells.
    Hirano T; Teranishi T; Lin B; Onoue K
    J Immunol; 1984 Aug; 133(2):798-802. PubMed ID: 6234360
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of a T4+/Leu-8+ T cell clone that directly helps B cell Ig production by secreting B cell differentiation factor.
    Goldstein H; Volkman DJ; Ambrus JL; Fauci AS
    J Immunol; 1985 Jul; 135(1):339-43. PubMed ID: 3923106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The roles of T cell factors in activation, cell cycle progression, and differentiation of human B cells.
    Jelinek DF; Lipsky PE
    J Immunol; 1985 Mar; 134(3):1690-701. PubMed ID: 3871457
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells.
    Smeland EB; Beiske K; Ohlsson R; Holte H; Ruud E; Blomhoff HK; Jefferis R; Godal T
    J Immunol; 1987 May; 138(10):3179-84. PubMed ID: 3553323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression and function of an early activation marker restricted to human B cells.
    Kikutani H; Kimura R; Nakamura H; Sato R; Muraguchi A; Kawamura N; Hardy RR; Kishimoto T
    J Immunol; 1986 Jun; 136(11):4019-26. PubMed ID: 3084651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells.
    Vazquez A; Auffredou MT; Gerard JP; Delfraissy JF; Galanaud P
    J Immunol; 1987 Oct; 139(7):2344-8. PubMed ID: 3116080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF).
    Procopio AD; Allavena P; Ortaldo JR
    J Immunol; 1985 Nov; 135(5):3264-71. PubMed ID: 3876382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of BCGFII in the differentiation to antibody secretion normal and tumor B cells.
    Swain SL
    J Immunol; 1985 Jun; 134(6):3934-43. PubMed ID: 2580899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human peripheral blood monocytes release a 30,000 dalton factor (30 KD MF) that stimulates immunoglobulin production by activated B cells.
    Rossen RD; Laughter AH; Orson FM; Flagge FP; Cashaw JL; Sumaya CV
    J Immunol; 1985 Nov; 135(5):3289-97. PubMed ID: 3930602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).
    Callard RE; Lau YL; Shields JG; Smith SH; Cairns J; Flores-Romo L; Gordon J
    Immunology; 1988 Nov; 65(3):379-84. PubMed ID: 3145248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the cell surface receptors for human B cell growth factor of 12,000 molecular weight.
    Mehta SR; Grant SR; Maizel AL
    J Immunol; 1986 Oct; 137(7):2210-4. PubMed ID: 3093567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.